The writer TRMT6 was reported to be significantly upregulated in hepatocellular carcinoma (HCC) tissues compared to adjacent tissues, and higher expression of TRMT6 was correlated with poor prognosis in HCC patients (13). This evidence concerns the gene TRMT6 and hepatocellular carcinoma.